Publications
69
Citations
222
Est. group size
—
Recurring co-author estimate
Active years
12
Publishing since 2015
Typically publishes in teams of ~4 · 19% small-team papers (≤3 authors) · across 9 venues
- Removal of Mini-Sling Anchor With Magnetic Resonance Imaging–Guided Site Marking With Methylene Blue
O&G Open · 2026
- Tranexamic acid for the treatment of postpartum hemorrhage: a cost-effectiveness analysis
American Journal of Obstetrics & Gynecology MFM · 2022
- Vaginal preparation with povidone-iodine or chlorhexidine before hysterectomy: a propensity score matched analysis
American Journal of Obstetrics and Gynecology · 2021
- Maternal body-mass-index and neonatal brachial plexus palsy in a California cohort
The Journal of Maternal-Fetal & Neonatal Medicine · 2021
- 847 Elective induction of labor at 38 weeks during the COVID-19 pandemic: a cost-effectiveness analysis
American Journal of Obstetrics and Gynecology · 2021
- 17 Postoperative infectious morbidity after hysterectomy: A propensity-matched analysis comparing vaginal preparation with povidone iodine versus chlorhexidine
American Journal of Obstetrics and Gynecology · 2021
- Maternal and Neonatal Hospitalization Costs Associated With Elective Induction of Labor at Term in California, 2007–2011
Obstetrics and Gynecology · 2020
- Extending the second stage of labor in nulliparous women with epidural analgesia: a cost-effectiveness analysis
The Journal of Maternal-Fetal & Neonatal Medicine · 2020
- Cost-effectiveness of second curettage for treatment of low-risk non-metastatic gestational trophoblastic neoplasia
Gynecologic Oncology · 2020
- Induction of Labor at 39 Weeks of Gestation Versus Expectant Management for Low-Risk Nulliparous Women: A Cost-effectiveness Analysis
Obstetric Anesthesia Digest · 2020
- First trimester fasting plasma glucose screen in advanced maternal age women: a cost-effectiveness analysis
The Journal of Maternal-Fetal & Neonatal Medicine · 2020
- Second Curettage for Treatment of Low-Risk Gestational Trophoblastic Neoplasia: A Cost-Effectiveness Analysis
Gynecologic Oncology · 2020
- First trimester fasting plasma glucose screen in advanced maternal age women: a cost-effectiveness analysis
Figshare · 2020
- Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis
American Journal of Obstetrics and Gynecology · 2019
- Induction of Labor at 39 Weeks of Gestation Versus Expectant Management for Low-Risk Nulliparous Women: A Cost-Effectiveness Analysis
Obstetrical & Gynecological Survey · 2019
- American Journal of Obstetrics and Gynecology×39
- Obstetrics and Gynecology×17
- The Journal of Maternal-Fetal & Neonatal Medicine×4
- Gynecologic Oncology×3
- American Journal of Obstetrics & Gynecology MFM×1
- William A. Grobman
Medicine · The Ohio State University
- Nasim C. Sobhani
Medicine · The Ohio State University
- Alan Tita
Medicine · The Ohio State University
- Jennifer L. Grasch
Medicine · The Ohio State University
- Heather A. Frey
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile